← Oncology Approval Tracker

FDA DECISION ·

Xeloda

capecitabine · Genentech

FDA approvalNew or expanded indicationColorectal cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Use alone or within a combination chemotherapy regimen for colorectal cancer that is unresectable or metastatic.

LAMPGEN ANALYSIS

Why it matters

The revised label clarifies how this oral fluoropyrimidine can be used in advanced colorectal cancer.

What research teams should watch

Capture the regimen partners, route and dose schedule. Document how adherence and toxicity will be monitored.

PRIMARY RECORDS

Sources